Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Warnken

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The Journal of Clinical Investigation|May 12, 2010
Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionationPhilipp Beckhove, Rolf Warta, Britt Lemke, et al.
Neuro-Oncology Advances|August 3, 2022
AAMP is a binding partner of costimulatory human B7-H3Sara Ciprut, Anne Berberich, Maximilian Knoll, et al.
Nature|April 2, 2011
Linear ubiquitination prevents inflammation and regulates immune signallingBjörn Gerlach, Stefanie M Cordier, Anna C Schmukle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant GliomaSteffen Dettling, Slava Stamova, Rolf Warta, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Cell Stem Cell|June 13, 2017
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in GlioblastomaTobias L Haas, Maria Rita Sciuto, Lidia Brunetto, et al.
Journal of Neurochemistry|March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignanciesDominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Nature Communications|February 6, 2024
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1Ling Hai, Dirk C Hoffmann, Robin J Wagener, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Journal of Clinical Investigation|May 12, 2010
Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionationPhilipp Beckhove, Rolf Warta, Britt Lemke, et al.
Neuro-Oncology Advances|August 3, 2022
AAMP is a binding partner of costimulatory human B7-H3Sara Ciprut, Anne Berberich, Maximilian Knoll, et al.
Nature|April 2, 2011
Linear ubiquitination prevents inflammation and regulates immune signallingBjörn Gerlach, Stefanie M Cordier, Anna C Schmukle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant GliomaSteffen Dettling, Slava Stamova, Rolf Warta, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Cell Stem Cell|June 13, 2017
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in GlioblastomaTobias L Haas, Maria Rita Sciuto, Lidia Brunetto, et al.
Journal of Neurochemistry|March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignanciesDominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Nature Communications|February 6, 2024
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1Ling Hai, Dirk C Hoffmann, Robin J Wagener, et al.
Pageof 5